CHU de Montpellier at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

CHU de Montpellier takes part in 2 sessions at CTAD 2026 in Boston. Its program pairs a next-generation tau immunotherapy with a national registry of people carrying two copies of APOE4. Its work covers primate data on the NIDB-3101 antibody and the ALZEVIT registry for prevention trials.

OrganizationCTAD 2026 Attendance
CHU de Montpellier
Montpellier, France
Poster
Wed Nov 18
7:15am–5:30pm
Poster
Thu Nov 19
7:15am–5:00pm

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from CHU de Montpellier

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction